Ignite Creation Date:
2024-05-06 @ 4:19 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04940325
Status:
RECRUITING
Last Update Posted:
2021-06-25
First Post:
2021-06-03
Brief Title:
Datopotamab DS-1062a in Advanced andor Unresectable Non-Small Cell Lung Cancer
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Lung Cancer |
Keywords:
| Name | View |
|---|---|
| Metastatic Lung Cancer | View |
| Advanced lung cancer | View |
| Antibody drug conjugate | View |
| ADC | View |
| Non small Cell lung Cancer | View |
| NSLC | View |
| Advanced non small Cell lung Cancer | View |
| Metastatic non small Cell lung Cancer | View |
| Datopotamab deruxtecan | View |
| Refractory NSCLC | View |
| Refractory Non small Cell lung Cancer | View |
| DS-1062 | View |
| DS-1062a | View |
| unresectable lung cancer | View |
| unresectable non small Cell lung Cancer | View |
| Advanced NSCLC | View |
| Metastatic NSCLC | View |
| Unresectable NSCLC | View |